poisar

Stock

Zai Lab Limited ZLAB

$26.82+3.03%

Overview

ZLAB market data

Price History

ZLAB price chart · 1M
O
27.17
H
27.17
L
26.65
C
26.82
Vol
33,735.00
Source
US equities market feed
Observed
Aug 27, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$27.17
Previous Close
$26.03
Day High
$27.17
Day Low
$26.65
52 Week High
$27.33
52 Week Low
$16.28
7 Day Return
+3.07%
30 Day Return
+43.88%
90 Day Return
+51.53%
1 Year Return
+29.07%
Daily Notional Volume
$904.8K
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$0.16
Diluted earnings per share over the trailing twelve months.
Beta
0.46
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-41.9%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$12.31 – $27.36
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $23.2B · P/B 2.75 · P/S 6.57.

Company News

6 captured
Citigroup Maintains Buy on Zai Lab, Raises Price Target to $45Benzinga · Aug 7, 2026, 8:12 PM
Zai Lab shares are trading higher after the company reported better-than-expected Q2 sales results.Benzinga · Aug 6, 2026, 6:35 PM
8-K filing — Zai Lab Ltd (ZLAB)SEC EDGAR · Aug 6, 2026, 10:34 AM
Zai Lab Q2 EPS $(0.46) Misses $(0.06) Estimate, Sales $105.751M Beat $105.323M EstimateBenzinga · Aug 6, 2026, 10:32 AM
Zai Lab Says FDA Grants Orphan Drug Designation To Zocilurtatug Pelitecan, Delta-Like Ligand 3 Antibody-Drug Conjugate, For Treatment Of Neuroendocrine CarcinomasBenzinga · Aug 3, 2026, 11:27 AM
Zai Lab Announces EMA Grants Orphan Drug Designation To Zocilurtatug Pelitecan, Delta-Like Ligand 3-Targeting Antibody-Drug Conjugate, For Treatment Of Pulmonary Neuroendocrine CarcinomasBenzinga · Jun 16, 2026, 11:20 AM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock